Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jul-24 5:54 PM View:  | Zevra Therapeutics, Inc. (ZVRA) | 17-Jul-24 | Private Purchase | 2,000 | $6.77 | $13,540.00 | 12% 16.47K to 18.47K | |
| 06-Sep-23 5:11 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 06-Sep-23 | Private Purchase | 1,000 | $4.96 | $4,959.10 | 7% 14.31K to 15.31K | |
| 18-May-23 4:56 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-May-23 | Private Purchase | 2,740 | $4.95 | $13,561.90 | 25% 11.0K to 13.74K | |
| 13-Mar-23 7:56 AM View: | Zevra Therapeutics, Inc. (ZVRA) | 10-Mar-23 | Private Purchase | 1,725 | $4.15 | $7,158.75 | 19% 9.28K to 11.0K | |
| 13-Jan-23 5:28 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 13-Jan-23 | Private Purchase | 635 | $5.81 | $3,689.82 | 7% 8.64K to 9.28K | |
| 03-Oct-22 7:57 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 30-Sep-22 | Private Purchase | 1,000 | $5.98 | $5,981.20 | 14% 7.11K to 8.11K | |
| 18-May-22 5:17 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-May-22 | Private Purchase | 1,200 | $5.00 | $5,999.04 | 23% 5.24K to 6.44K | |
| 18-Nov-21 4:57 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-Nov-21 | Market Purchase | 510 | $8.29 | $4,227.90 | 11% 4.73K to 5.24K | < 1% |
| 29-Sep-21 4:10 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 29-Sep-21 | Market Purchase | 215 | $9.38 | $2,016.70 | 5% 4.51K to 4.73K | (2%) |
| 20-Sep-21 5:03 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 20-Sep-21 | Market Purchase | 935 | $8.59 | $8,028.38 | 26% 3.58K to 4.51K | 6% |
| 01-Sep-21 4:04 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 01-Sep-21 | Market Purchase | 230 | $9.10 | $2,094.15 | 7% 3.35K to 3.58K | 2% |
| 24-Jun-21 4:22 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 23-Jun-21 | Market Purchase | 75 | $14.11 | $1,058.25 | 2% 3.27K to 3.35K | 1% |
| 27-May-21 5:50 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 27-May-21 | Market Purchase | 150 | $9.85 | $1,477.50 | 5% 3.13K to 3.27K | < 1% |
| 26-Aug-20 5:08 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 26-Aug-20 | Private Purchase | 1,000 | $0.84 | $839.00 | 2% 49.0K to 50.0K | |
| 18-Aug-20 4:48 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 18-Aug-20 | Private Purchase | 2,000 | $0.69 | $1,390.00 | 4% 47.0K to 49.0K | |
| 11-Jun-20 4:10 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 11-Jun-20 | Private Purchase | 1,500 | $0.19 | $288.45 | 3% 45.5K to 47.0K | |
| 26-May-20 4:29 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 26-May-20 | Private Purchase | 11,500 | $0.18 | $2,104.50 | 34% 34.0K to 45.5K | |
| 25-Mar-20 5:37 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 25-Mar-20 | Private Purchase | 1,000 | $0.22 | $218.20 | 3% 33.0K to 34.0K | |
| 12-Mar-20 4:28 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 11-Mar-20 | Private Purchase | 8,000 | $0.25 | $2,010.40 | 32% 25.0K to 33.0K | |
| 30-Dec-19 4:26 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 27-Dec-19 | Private Purchase | 12,250 | $0.42 | $5,109.58 | 96% 12.75K to 25.0K | |
| 25-Sep-19 8:58 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 25-Sep-19 | Private Purchase | 3,650 | $0.75 | $2,719.98 | 40% 9.1K to 12.75K | |
| 16-Sep-19 4:59 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 16-Sep-19 | Private Purchase | 5,000 | $0.89 | $4,425.44 | 122% 4.1K to 9.1K | |
| 11-Sep-19 4:50 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 11-Sep-19 | Private Purchase | 500 | $0.95 | $472.60 | 14% 3.6K to 4.1K | |
| 06-Sep-19 5:06 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 06-Sep-19 | Private Purchase | 850 | $0.77 | $652.29 | 31% 2.75K to 3.6K | |
| 11-Oct-18 6:52 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 11-Oct-18 | Market Purchase | 650 | $2.54 | $1,651.91 | 31% 2.1K to 2.75K | (9%) |
| 01-Jun-18 4:14 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 31-May-18 | Market Purchase | 525 | $6.10 | $3,202.50 | 33% 1.57K to 2.1K | (62%) |
| 25-Sep-17 4:33 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 25-Sep-17 | Market Purchase | 300 | $3.78 | $1,132.50 | 24% 1.27K to 1.57K | (38%) |
| 21-Jun-17 8:57 AM View: | Zevra Therapeutics, Inc. (ZVRA) | 19-Jun-17 | Market Purchase | 275 | $3.30 | $907.50 | 28% 1.0K to 1.27K | (30%) |
| 27-Mar-17 4:28 PM View: | Zevra Therapeutics, Inc. (ZVRA) | 24-Mar-17 | Market Purchase | 1,000 | $4.24 | $4,243.69 | 100% 0 to 1.0K | (45%) |
| 28-Mar-13 5:18 PM View: | The LGL Group, Inc. (LGL) | 26-Mar-13 | Grant | 2,229 | -- | -- | 43% 5.21K to 7.43K | |
| 05-Mar-12 8:58 AM View: | The LGL Group, Inc. (LGL) | 29-Feb-12 | Grant | 1,600 | -- | -- | 44% 3.61K to 5.21K | |
| 01-Sep-11 4:36 PM View: | The LGL Group, Inc. (LGL) | 31-Aug-11 | Market Purchase | 51 | $7.70 | $392.70 | 1% 3.56K to 3.61K | 24% |
| 19-May-11 1:52 PM View: | The LGL Group, Inc. (LGL) | 17-May-11 | Market Purchase | 50 | $11.15 | $557.50 | 1% 3.5K to 3.56K | (15%) |
| 21-Dec-10 9:39 PM View: | The LGL Group, Inc. (LGL) | 15-Dec-10 | Grant | 2,080 | -- | -- | 146% 1.43K to 3.5K | |
| 23-Jul-10 4:13 PM View: | The LGL Group, Inc. (LGL) | 21-Jul-10 | Grant | 1,225 | -- | -- | 612% 0.2K to 1.43K | |
| 08-Apr-10 5:55 PM View: | The LGL Group, Inc. (LGL) | 07-Apr-10 | Market Purchase | 200 | $6.20 | $1,240.00 | 100% 0 to 0.2K | 60% |